Cargando…
Dosimetric Impact of Inter-Fraction Anatomical Changes in Carbon Ion Boost Treatment for High-Risk Prostate Cancer (AIRC IG 14300)
Rectum and bladder volumes play an important role in the dose distribution reproducibility in prostate cancer adenocarcinoma (PCa) radiotherapy, especially for particle therapy, where density variation can strongly affect the dose distribution. We investigated the reliability and reproducibility of...
Autores principales: | Russo, Stefania, Ricotti, Rosalinda, Molinelli, Silvia, Patti, Filippo, Barcellini, Amelia, Mastella, Edoardo, Pella, Andrea, Paganelli, Chiara, Marvaso, Giulia, Pepa, Matteo, Comi, Stefania, Zaffaroni, Mattia, Avuzzi, Barbara, Giandini, Tommaso, Pignoli, Emanuele, Valdagni, Riccardo, Baroni, Guido, Cattani, Federica, Ciocca, Mario, Jereczek-Fossa, Barbara Alicja, Orlandi, Ester, Orecchia, Roberto, Vischioni, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506150/ https://www.ncbi.nlm.nih.gov/pubmed/34650922 http://dx.doi.org/10.3389/fonc.2021.740661 |
Ejemplares similares
-
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300
por: Marvaso, Giulia, et al.
Publicado: (2021) -
Radioablation +/− hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)
por: Marvaso, Giulia, et al.
Publicado: (2019) -
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy
por: Isaksson, Lars J., et al.
Publicado: (2020) -
Time‐resolved MRI for off‐line treatment robustness evaluation in carbon‐ion radiotherapy of pancreatic cancer
por: Meschini, Giorgia, et al.
Publicado: (2022) -
Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer
por: Marvaso, Giulia, et al.
Publicado: (2022)